Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (abre uma nova janela)

Ball AM, Winstead PS.

Fonte‎: Pharmacotherapy 2008;28(11):1383-90.

Indexado‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (abre uma nova janela)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (abre uma nova janela)

Charles A, Purtill M, Napolitano LM.

Fonte‎: Anaesth Intensive Care 2006;34(6):793-6.

Indexado‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (abre uma nova janela)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (abre uma nova janela)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Fonte‎: N Engl J Med. 2023 2;389(18):1649-59.

Indexado‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (abre uma nova janela)

Bloodless management of the anemic patient in the emergency department. (abre uma nova janela)

Johnson-Arbor K, Verstraete R

Fonte‎: Ann Emerg Med 2022;79(1):48-57.

Indexado‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (abre uma nova janela)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (abre uma nova janela)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Fonte‎: J Trauma 2008;65(2):285-97.

Indexado‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (abre uma nova janela)

Erythropoiesis in multiply injured patients. (abre uma nova janela)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Fonte‎: J Trauma 2006;61(5):1285-91.

Indexado‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (abre uma nova janela)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (abre uma nova janela)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Fonte‎: Arch Surg 2012;147(3):251-5.

Indexado‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (abre uma nova janela)

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] (abre uma nova janela)

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

Fonte‎: Chirurg 2011;82(6):531-5.

Indexado‎: PubMed 21088815

DOI‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 (abre uma nova janela)